✦ LIBER ✦

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP

✍ Scribed by Jorge J. Castillo; Brady E. Beltran; Moo-Kon Song; Ivana Ilic; Sirpa Leppa; Heidi Nurmi; Ritsuko Seki; Silvia Uccella; Jun-Min Li; Diana O. Treaba; Dariusz Stachurski; James N. Butera

Book ID: 113773637
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 385 KB
Volume: 36
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2011.12.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic impact of activated B-cell fo

Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP

✍ Nyman, Heidi; Jerkeman, Mats; Karjalainen-Lindsberg, Marja-Liisa; Banham, Alison 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 185 KB

Serum interleukin-18 level is associated

Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens

✍ Naoe Goto; Hisashi Tsurumi; Senji Kasahara; Nobuhiro Kanemura; Takeshi Hara; Ich 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Gains of MYC locus and outcome in patien

Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

✍ Monica Testoni; Ivo Kwee; Timothy C. Greiner; Santiago Montes-Moreno; Julie Vose 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Limited role of interim PET/CT in patien

Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP

✍ Changhoon Yoo; Dae Ho Lee; Jeong Eun Kim; Jungmin Jo; Dok Hyun Yoon; Byeong Seok 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 139 KB

The Hans classificator does not predict

The Hans classificator does not predict outcome in diffuse large B cell lymphoma in a large multicenter retrospective analysis of R-CHOP treated patients

✍ M. Michaela Ott; Heike Horn; Martin Kaufmann; German Ott 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Serum soluble Fas level determines clini

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

✍ Takeshi Hara; Hisashi Tsurumi; Naoe Goto; Nobuhiro Kanemura; Takeshi Yoshikawa; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 390 KB